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Abstract
Aggregation of TAR-DNA-binding protein 43 (TDP-43) and of its fragments TDP-25 and TDP-35 occurs in amyotrophic lateral
sclerosis (ALS). TDP-25 and TDP-35 act as seeds for TDP-43 aggregation, altering its function and exerting toxicity. Thus,
inhibition of TDP-25 and TDP-35 aggregation and promotion of their degradation may protect against cellular damage.
Upregulation of HSPB8 is one possible approach for this purpose, since this chaperone promotes the clearance of an ALS asso-
ciated fragments of TDP-43 and is upregulated in the surviving motor neurones of transgenic ALS mice and human patients.
We report that overexpression of HSPB8 in immortalized motor neurones decreased the accumulation of TDP-25 and TDP-35
and that protection against mislocalized/truncated TDP-43 was observed for HSPB8 in Drosophila melanogaster. Overexpression
of HSP67Bc, the functional ortholog of human HSPB8, suppressed the eye degeneration caused by the cytoplasmic accumula-
tion of a TDP-43 variant with a mutation in the nuclear localization signal (TDP-43-NLS). TDP-43-NLS accumulation in retinal
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cells was counteracted by HSP67Bc overexpression. According with this finding, downregulation of HSP67Bc increased eye de-
generation, an effect that is consistent with the accumulation of high molecular weight TDP-43 species and ubiquitinated
proteins. Moreover, we report a novel Drosophila model expressing TDP-35, and show that while TDP-43 and TDP-25 expres-
sion in the fly eyes causes a mild degeneration, TDP-35 expression leads to severe neurodegeneration as revealed by pupae
lethality; the latter effect could be rescued by HSP67Bc overexpression. Collectively, our data demonstrate that HSPB8
upregulation mitigates TDP-43 fragment mediated toxicity, in mammalian neuronal cells and flies.
Introduction
Amyotrophic lateral sclerosis (ALS) is the most common adult-
onset motor neurone disease, which leads to progressive mus-
cle weakness and eventual respiratory failure. ALS is a complex
disease that develops in familial (fALS) forms, associated with
specific gene mutations in 5–10% of the cases and in sporadic
(sALS) forms in the remaining 90% of patients (1). The vast ma-
jority of ALS patients show mislocalization and accumulation of
the TAR-DNA-binding protein 43 (TDP-43) in affected tissues.
Accumulation of TDP-43 is also evident in other neurodegenera-
tive diseases such as frontotemporal lobar degeneration with
ubiquitin-positive inclusions (FTLD-U) and Alzheimer’s disease
(AD) (2–4).
TDP-43 is a predominantly nuclear protein that belongs to
the family of heterogeneous nuclear ribonucleoproteins
(hnRNPs) and functions in RNA processing (RNA splicing and
microRNA biogenesis (5,6)). TDP-43 possesses two RNA recogni-
tion motifs (RRMs), a nuclear localization sequence (NLS), a nu-
clear export signal (NES) and a C-terminal glycine-rich domain.
Upon cleavage by caspases at intrinsic caspase cleavage sites,
TDP-43 generates two major (but not exclusive (3,7,8)) C-termi-
nal fragments (CTF): the 25 kDa TDP-43 (TDP-25) and the 35 kDa
TDP-43 (TDP-35) (7). The two fragments differ in the context
that TDP-35 retains both the RRM1 and RRM2 sequences, while
only the RRM2 is preserved in TDP-25. It is not clear if this differ-
ence can differentially affect TDP-25 and TDP-35 activity, al-
though it has been suggested that only TDP-35 is also able to
deregulate pre-RNA splicing (5,9). Both TDP-25 and TDP-35 frag-
ments lack the NLS and retain the NES, thus both mislocalize to
the cytoplasm and both are highly aggregation-prone (10).
In addition, experiments in several different cellular models
have shown that both TDP-25 and TDP-35 form detergent-
insoluble ubiquitin-positive cytoplasmic inclusions. These in-
clusions sequester endogenous TDP-43 (11) and correlate with
reduced TDP-43 levels in the nucleus (12). These TDP-43 aggre-
gates have been documented in almost all cases of sALS and
fALS, except for SOD1-linked fALS, and are characterized by the
invariable presence of phosphorylated forms of full-length (FL)
and fragmented TDP-43; thus TDP-43 aggregation is considered
as a pathological signature for ALS (3,7). The seeding by the
TDP-25 fragment seems to be required to generate insoluble FL
TDP-43-positive aggregates in the cytoplasm (7). TDP-43 and its
fragments can be degraded by all intracellular degradative sys-
tems (i.e. by the proteasome, macroautophagy, and also by
chaperone-mediated autophagy/CMA), but the proteasome-
mediated degradation appears to be the preferred route for its
disposal (7). In ALS and FTLD-U, when the proteasome is im-
paired (or overwhelmed) the TDP-35 species accumulate at
higher levels than the TDP-25 species, indicating that the two
fragments may have different clearance mechanisms, aggrega-
tion properties and/or toxicity (13).
Independently of which specific form is more aggregation-
prone or toxic, since inclusions formed by truncated TDP-25
and TDP-35 cleavage fragments are associated with enhanced
cellular toxicity, all approaches aimed at decreasing their aggre-
gation rate and facilitating their disposal may represent suc-
cessful strategies to counteract motor neurone degeneration in
ALS. One way of achieving this objective could be to boost the
protein quality control (PQC) system, which survey protein fold-
ing/aggregation and assist protein clearance. Indeed, we have
already demonstrated that upregulation of the small heat shock
protein HSPB8 (a member of the mammalian sHSP/HSPB family)
(14), might represent a possible approach mitigating the accu-
mulation of TDP fragments. In particular, in motor neurone cells
HSPB8 decreases the aggregation and enhances the autophagy-
mediated degradation of a C-terminal truncated fragment of
TDP-43 (DC-TDP-43) originating from the frameshift mutation
p.Y374X (15,16), while its pharmacological upregulation reduces
the accumulation of all species deriving from FL TDP-43 and
from the TDP-25 fragment (17). In addition, HSPB8 levels are
upregulated in the motor neurones that survive in the spinal
cord (15) and affected muscles (18) of transgenic G93A-SOD1
mice, as well as in the spinal cord of ALS patients (19). Finally,
HSPB8 mutations (K141E and K141N) have been associated with
motor neurone diseases (20–23), further strengthening the
hypothesis that alteration of HSPB8 function could have a
significant impact on motor neurone viability and that its
potentiation/upregulation could help protect against disease.
Based on these findings, we have studied the accumulation
and aggregation of TDP-25 and TDP-35 in mammalian motor
neurone cells and in the model organism Drosophila melanogaster
(Dm). We find that overexpression of HSPB8 and its Dm func-
tional ortholog HSP67Bc (24) can significantly decrease trun-
cated and mutant TDP-43 mediated aggregation in cells and eye
degeneration in fruitfly, respectively.
Results
Evaluation of the biochemical behaviour of GFP-tagged
FL TDP-43 and of the two GFP-tagged fragments TDP-35
and TDP-25 in immortalized motor neurone cells
We characterized the biochemical behaviour of the GFP-tagged
FL TDP-43 and the two major fragments derived from its cas-
pase cleavage TDP-35 and TDP-25 in immortalized motor neu-
rone NSC34 cells. By transiently overexpressing the different
N-terminal GFP-tagged TDP variants, or GFP itself (using pEGFP-
N1 plasmid), we found that, while GFP was distributed in a dif-
fuse manner, GFP-TDP-43 was confined to the nucleus in the
vast majority of motor neurones, while both GFP-TDP-35 and
GFP-TDP-25 were observed to be mislocalized to the cytoplasm
(Figure 1A). Cells transfected with GFP-TDP-25 formed aggre-
gates in a large fraction of cases (62.7 6 13.7% of cells) compared
with those transfected with GFP-TDP-43 (8.0 6 4.9% of cells) and
GFP-TDP-35 (30.0 6 14.1% of cells) (Figure 1A). The GFP-TDP-25
aggregates appeared as large rounded inclusions localized and
dispersed in the cell cytoplasm, while GFP-TDP-35 had accumu-
lated both in the nucleus, where it was characterized by a
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diffuse pattern and in the cytoplasm, where it formed aggre-
gates (Figure 1A). We next analysed the solubility properties
of the different TDP variants in immortalized motor neurones
using two techniques: western blot (WB) and filter retardation
assay (FRA). While the WB assay is designed for detection of the
protein in its monomeric form solubilized by SDS, as well as
SDS-resistant oligo-heteromeric species, FRA allows the mea-
surement of the PBS-resistant TDP aggregates accumulating in
the same samples. The WB data showed that the levels of mo-
nomeric SDS-soluble GFP-TDP-25 were much higher than those
of GFP-TDP-43 and GFP-TDP-35, whose levels were comparable
to each other (Figure 1B, upper panel). In contrast, by FRA we
Figure 1. GFP-tagged truncated TDP-35 and TDP-25 show different biochemical behaviour from that of full-length TDP-43. (A) Confocal microscopy analysis (63 mag-
nification) of mouse motor neurone NSC34 cells transiently overexpressing GFP-TDP-43, GFP-TDP-35, GFP-TDP-25, or GFP alone (pEGFP-N1, used as a control). DAPI: nu-
clei staining. A 2.5x magnification of selected areas is shown. (B): Western Blot (WB; upper insets) and filter retardation assay (FRA, lower inset) of the PBS extracts of
mouse motor neurone NSC34 cells transiently overexpressing the GFP-TDP-43, GFP-TDP-35 or GFP-TDP-25. (C) Quantification of the PBS extract by FRA (***P<0.001 vs
GFP-TDP-43). The data represent in each case the mean 6 sem of n¼3 independent samples. (D): WB (upper insets) and FRA (lower insets) of the NP40 extracts of cells
transiently overexpressing GFP-TDP-43, GFP-TDP-35 or GFP-TDP-25 (left insets, NP40-soluble fraction; right insets, NP40-insoluble fraction). (E): Quantification of
FRA NP40 insoluble/soluble ratio (P<0.001 vs GFP-TDP-43; * P<0.05 vs GFP-TDP-43; ### P<0.001 vs GFP-TDP-35). The data again represent the mean 6 sem of n¼3
independent samples.
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observed that the levels of PBS-resistant aggregated GFP-TDP-43
were much higher than those of GFP-TDP-35 and GFP-TDP-25
(Figure 1B, lower inset and 1C, quantification bar graph). This
finding is in contrast to our immunofluorescence data demon-
strating a high tendency of GFP-TDP-25 to form cytoplasmic ag-
gregates and suggests that detergents are required to extract
and solubilize at least some fractions of aggregated GFP-TDP-25
and GFP-TDP-35. Indeed, when using a lysis buffer containing
the detergent NP40, we could detect a significant accumulation
of GFP-TDP-25 in the NP40-insoluble fraction, while the levels of
NP40-soluble GFP-TDP-43, GFP-TDP-35 and GFP-TDP-25 were all
similar (Figure 1D and E). Thus, the aggregates visible by immu-
nofluorescence are most likely to correspond to NP40-insoluble
GFP-TDP-25 species. The data obtained using NP40 lysis buffer
and immunofluorescence, however, reveal that TDP-25 and
TDP-35 fragments have different aggregation properties, with
the TDP-35 fragment being much more soluble than the TDP-25
fragment.
The role of the degradative systems on the solubility
of GFP-tagged FL TDP-43 and of the two GFP-tagged
fragments TDP-35 and TDP-25 in mammalian motor
neurone cells
The aggregation propensity of TDP-25 versus TDP-43 and TDP-
35 might depend not only on the intrinsic properties of these
different species but also on the ability of the cell to clear them.
If differences in the turnover of the cleaved TDP-43 fragments
exist, their clearance should be differentially affected when
the degradative systems are pharmacologically impaired.
Therefore, we analysed how inhibition of the proteasome and
of autophagy impacts on the intracellular levels of the different
GFP-TDP variants. In this assay, we use the NP40 fractionation
method, which, according to our results, is the most suitable
method to analyse the accumulation of GFP-TDP aggregates.
Inhibition of autophagy or of the proteasome system mildly in-
creased the levels of the NP40-soluble monomeric forms of GFP-
TDP-43 and GFP-TDP-35, while leaving monomeric NP40-soluble
GFP-TDP-25 unaffected (Figure 2A). In contrast, monomeric
NP40-insoluble (SDS-soluble) GFP-TDP-25 accumulated signifi-
cantly in immortalized motor neurones after inhibition of both
the proteasome and autophagy (Figure 2B). A small increase in
the levels of monomeric NP40-insoluble (SDS-soluble) GFP-TDP-
35 was detected exclusively after proteasome inhibition, while
no changes were observed in the case of GFP-TDP-43 (Figure 2B
and C). These data suggest that all the GFP-TDP variants can be
processed by the proteasome and tend to accumulate when this
degradative pathway is overwhelmed and/or impaired, while
the levels of the TDP-25 fragment, which has a higher aggrega-
tion propensity also depends on a functional autophagic flux
for proper clearance. This finding is in line with the role of
autophagic vacuoles in the engulfment and degradation of pro-
teinaceous aggregates and with the experimental evidence
that autophagy efficiently clears aggregates, protecting against
misfolded protein mediated toxicity (25,26).
The effects of HSPB8 on the solubility and clearance
of GFP-tagged FL TDP-43 and of the two GFP-tagged
fragments TDP-35 and TDP-25 in immortalized motor
neurone cells
The observation that HSPB8 expression is enhanced by the
expression of both GFP-TDP-35 and GFP-TDP-25 fragments
(Figure 2A, WB lanes 2 and 3), prompted us to evaluate the effect
of this chaperone on the three TDP variants. We previously re-
ported that HSPB8 enhances the autophagy-mediated clearance
of DC-TDP-43, the N-terminal fragment of TDP-43 (15,16), found
in some patients affected by fALS (frameshift mutation
p.Y374X) (27). In addition, HSPB8 has been found to be upregu-
lated in the surviving motor neurones in ALS mice and in ALS
patients, supporting the view that this chaperone may exert a
beneficial effect on motor neurone survival (15). Intriguingly, as
stated above, HSPB8 was significantly upregulated in NSC34
cells transfected with GFP-TDP-35 and GFP-TDP-25 as compared
to those transfected with GFP-TDP-43 (Figure 2A, untreated
Figure 2. GFP-TDP-35 and GFP-TDP-25 show different clearance from that of
full-length GFP-TDP-43. (A) WB (upper insets) and FRA (lower insets) of the
NP40-soluble extracts of mouse motor neurone NSC34 cells transiently overex-
pressing GFP-TDP-43, GFP-TDP-35 or GFP-TDP-25 and treated with 10mM MG132
for 16 h or 10 mM 3-methyladenine (3-MA) for 32 h. (B) WB (upper insets)
and FRA (lower insets) of NP40-insoluble extracts. (C) Quantification of FRA NP40
insoluble/soluble ratios (***P<0.001 vs GFP-TDP-43). The data represent the
mean6 sem of n¼3 independent samples.
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cells), which may represent a response within the cells to facili-
tate the clearance of these aberrant TDP species. Interestingly,
we found that endogenous HSPB8 (mHSPB8) co-localized with
the large GFP-TDP-35 inclusions (Figure 3A, arrows) and with all
the GFP-TDP-25 aggregates (Figure 3A, arrows). Overexpression
of human HSPB8 (hHSPB8) in NSC34 cells transiently transfected
with the three different TDP variants almost completely abro-
gated GFP-TDP-35 and GFP-TDP-25 aggregation, with a parallel
increase of the soluble TDP forms (Figure 3B). The anti-
aggregation function of HSPB8 on different TDP species was fur-
ther investigated by WB. In line with our immunofluorescence
results, HSPB8 overexpression slightly decreased the mono-
meric NP40-soluble levels of all TDP species (Figure 3C), while
it significantly inhibited the accumulation of NP40-insoluble
GFP-TDP-25 (Figure 3D).
To probe further, the importance of HSPB8 for the degrada-
tion of GFP-TDP fragments we performed silencing experiments
in inducible stably-transfected GFP-TDPs-NSC34 cell lines that
expressed comparable levels of GFP-TDPs mRNA (data not
shown). In these cells, HSPB8 silencing resulted in a significant
increased accumulation of both GFP-TDP-35 and GFP-TDP-25
NP40-soluble species retained by cellulose acetate membranes
(Figure 3 E–G). Consistent with our previous results, inhibition
of the proteasome and of autophagy leads to accumulation of
GFP-TDP-35 or GFP-TDP-25, but leaves GFP-TDP-43 unaffected
(Figure 3 E–G). Taken together, these results support the conclu-
sion that the protein quality control system participates in the
clearance of truncated TDP-35 and TDP-25 and highlight HSPB8
as one of the critical players required for this action.
In immortalized motor neurone cells, FLAG-tagged
TDP-35 and TDP-25 mislocalize to the cytosol and are
cleared in a proteasome and autophagy-dependent
manner
As the GFP tag has the potential to influence the stability, distri-
bution and/or aggregation properties of truncated TDP-43, we
repeated our experiments using a FLAG tag instead of GFP; the
smaller size of the former is likely to reduce any perturbation
effects. We therefore produced N-terminal FLAG-tagged TDP
variants (2xFLAG-TDP-43, 2xFLAG-TDP-35 and 2xFLAG-TDP-25),
and characterized their biochemical behaviour after transient
overexpression in immortalized motor neurone NSC34 cells.
Similarly to the GFP-tagged TDPs described above, 2xFLAG-TDP-
43 was found to be confined to the nucleus with very few cells
forming aggregates (7.14 6 1.36% of cells), while both 2xFLAG-
TDP-35 and 2xFLAG-TDP-25 were mislocalized into the cyto-
plasm (Figure 4A). However, while GFP-TDP-35 and GFP-TDP-25
formed cytosolic insoluble aggregates, FLAG-TDP-35 and FLAG-
TDP-25 accumulated at much lower levels and were mainly dif-
fuse in appearance, with only small aggregates visible in ca 20%
of transfected cells (20.0 6 2.53 and 19.80 6 2.80% of cells, re-
spectively), suggesting that FLAG-TDP-35 and FLAG-TDP-25
could be rapidly degraded by the cellular machineries. In line
with this interpretation, we found that in resting cells the solu-
ble and insoluble levels of FLAG-TDP-35 and, particularly of
FLAG-TDP-25, were much lower than those of FLAG-TDP-43.
However, both soluble and insoluble FLAG-TDP-35 and FLAG-
TDP-25 accumulated to very significantly greater levels upon
inhibition of the proteasome and of autophagy, supporting
the conclusion that they are targeted for degradation by both
systems (Figure 4C–E). Taken together, these results highlight
the fact that FLAG-TDP-35 and FLAG-TDP-25 have different
aggregation propensities from those of the GFP-tagged forms
(compare Figure 4C–E with Figure 3E–G); thus caution must be
taken when using large tags on such small proteins. However,
the results also demonstrate that TDP-43 and its truncated
forms are processed preferentially both by the proteasome and
by autophagy, regardless of the type of tag that was employed.
HSPB8 decreases the accumulation of FLAG-tagged TDP-
35 and TDP-25 in immortalized motor neurone cells
We next evaluated the effects of overexpression of HSPB8 on
the intracellular distribution and accumulation of the 2xFLAG-
tagged TDP-43, TDP-35 and TDP-25. Similarly to the observation
made using GFP-tagged TDP-43, TDP-35 and TDP-25, co-expres-
sion of HSPB8 decreased the accumulation of both soluble and
insoluble species of all 2xFLAG-tagged TDP variants as mea-
sured by WB (Figure 4F) and FRA (Figure 4F, lower inset and
Figure 4G–I). A decrease in the accumulation of soluble and
aggregated TDP-43 species by co-expression with HSPB8 was
further confirmed by confocal microscopy (Supplementary
Material, Fig. S1). In combination, these results further suggest
that HSPB8 participates in the disposal of accumulating and/or
mislocalized TDP43 variants independently on the type of tag
used.
Overexpression of HSP67Bc in flies reduces the
accumulation and toxicity of TDP-43-NLS
The Drosophila melanogsater (Dm) family of sHSPs comprises 11
members that have specific functions in the control of protein
homeostasis (28). We have previously identified HSP67Bc as the
Dm functional ortholog of human HSPB8 (24) and shown that it
promotes the autophagic flux in Drosophila S2 cells, facilitating
the degradation of a variety of misfolded proteins (24). This pro-
degradative effect of HSP67Bc has been shown, for example, to
result in a decrease of the total levels of mutated Ataxin 3, both
in cells and in Drosophila where it protects against eye degenera-
tion (24,28). Based on these findings, we asked whether or not
overexpression of HSP67Bc in fruit flies could protect against
the toxicity mediated by mutated TDP-43.
Ubiquitous overexpression of both WT TDP-43 and a mutant
lacking the nuclear localization signal (NLS) have been shown
to result in premature lethality in flies (29). This finding is con-
sistent with the observation that the accumulation of TDP-43 in
the cytoplasm of cultured cells, generated by mutating key resi-
dues in TDP-43 NLS (30) or by deleting the entire NLS (31), leads
to aggregation and toxicity. We first confirmed the finding that
the ubiquitous overexpression of TDP-43 in flies leads to prema-
ture lethality, and thus we restricted the expression of TDP-43
in the fly eyes. In this study, we used transgenic fruit flies (here
referred to as TDP-43-NLS) that express a mutation variant of
TDP-43 in which Lys95, Lys97 and Arg98 are all substituted by
alanine residues; this variant has previously been characterized
for its toxicity in cells (30) and fly eyes (32). As control, we also
used the well-characterized fly line expressing WT TDP-43 in
the eyes. In agreement with published data (28), overexpression
of WT TDP-43 in the fly eyes caused a modest degree of degen-
eration, referred to as a rough eye phenotype (Figure 5A).
Overexpression of HSP67Bc in fly eyes did not by itself affect eye
morphology ((24) and Supplementary Material, S2A) and co-
expression of HSP67Bc with WT TDP-43 did not significantly af-
fect the eye phenotype caused by WT TDP-43, nor its expression
levels (Figure 5A,B). By contrast, expression in fly eyes of
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Figure 3. HSPB8 affects the accumulation of GFP-TDP-35 and GFP-TDP-25 fragments. (A,B) Confocal microscopy analysis (63 magnification) of NSC34 cells transiently
co-transfected with plasmids coding for GFP-TDP-43, GFP-TDP-35 or GFP-TDP-25 and pCDNA3 (A) or hHSPB8 plasmid (B). DAPI: nuclei staining. RED: murine endoge-
nous HSPB8 (mHSPB8) or human transfected HSPB8 (hHSPB8). A 2.5magnification of selected areas is shown. (C) WB of the NP40-soluble extracts of mouse motor neu-
rone NSC34 cells transiently overexpressing GFP-TDP-43, GFP-TDP-35 or GFP-TDP-25 and human HSPB8. (D): WB of the NP40-insoluble extracts. E-G: Representative
FRA (upper panels) and FRA quantification (lower panels) of the NP40-soluble and NP40-insoluble extracts of mouse motor neurone NSC34 cells stably overexpressing
GFP-TDP-43 (E), GFP-TDP-35 (F) or GFP-TDP-25 (G), induced for 72 h with 1 lg/ml doxycycline and transfected with scramble or siRNA-HSPB8; the cells were treated with
10lM MG132 and 10 mM 3-MA for the last 16 h prior to extraction. The optical densities of GFP-TDPs were expressed relative to the mean optical densities of the corre-
sponding samples treated with doxycycline and a scramble RNAi sequence, taken as internal references. The data represent the mean 6 sem of n¼3 independent
samples. (*P<0.05 vs scramble; ** P<0.01 vs scramble).
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Figure 4. Accumulation and clearance of FLAG-tagged TDP-43, TDP-35 and TDP-25. (A) Confocal microscopy analysis (63 magnification) of mouse motor neurone
NSC34 control cells or cells transiently overexpressing 2xFLAG-TDP-43, 2xFLAG-TDP-35, 2xFLAG-TDP-25. DAPI: nucleic acid staining. A 2.5x magnification image of
selected areas is shown. (B) WB (upper insets) and FRA (lower insets and FRA quantification, bar graph) of the PBS extracts of mouse motor neurone NSC34 cells tran-
siently overexpressing the 2xFLAG-TDP-43, 2xFLAG-35 or 2xFLAG-TDP-25. The data represent the mean 6 sem of n¼3 independent samples. ** P<0.001 vs 2xFLAG-
TDP-43;  P< 0.05 vs 2xFLAG-TDP-35. (C-E): WB (upper insets) and FRA (lower insets and FRA quantification, bar graph) of the PBS extracts of mouse motor neurone
NSC34 cells transiently overexpressing 2xFLAG-TDP-43 (C), 2xFLAG-35 (D) or 2xFLAG-TDP-25 (E) and treated with 10mM MG132 for 16 h or 10 mM 3-methyladenine
(3-MA) for 32 h (**P<0.001 or * P<0.01 vs untreated controls). The data represent the mean 6 sem of n¼3 independent samples. (F-I): NSC34 cells transiently co-trans-
fected with plasmids coding for 2xFLAG-TDP-43, 2xFLAG-TDP-35 or 2xFLAG-TDP-25 and pCDNA3 or hHSPB8. WB and representative FRA (F). FRA quantification
(G, TDP-43; H, TDP-35; I, TDP-25) (**P<0.001 vs pCDNA3 transfected cells). The data represent the mean 6 sem of n¼3 independent samples.
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NLS-mutant TDP-43 led to a strong degenerative phenotype,
characterized by rough and depigmented eyes, accompanied by
strong ommatidia disorganization (Figure 5C). Both the eye de-
generation and ommatida disorganization were significantly
rescued by co-expression of HSP67Bc with NLS-mutant TDP-43
(Figure 5C), finding that correlates with a significant decrease
in the total NLS-mutant TDP-43 protein levels as a result of the
presence of HSP67Bc (Figure 5D).
The decrease in the extent of eye degeneration and in the
total protein levels of mutant TDP-43 NLS observed in flies that
co-express HSP67Bc is likely to be due to its pro-degradative
function. To explore this issue further, we first used the UAS-
eGFP or the UAS-LacZ transgenes to control for the possibility
that the differences observed in the absence and presence of
HSP67Bc would be due to dilution effects of the GAL4 protein
with an increased number of UAS transgenes. We observed no
difference in the eye phenotype of flies expressing WT TDP-43
and the TDP-43-NLS mutant alone or with GFP or LacZ
(Supplementary Material, S2B and S2C). Second, we co-
expressed another member of the Drosophila sHSP family,
Figure 5. HSP67Bc rescues mutant eye degeneration mediated by TDP-43-NLS. (A) Representative pictures showing eyes from 1-day-old flies expressing human TDP-43
under the control of the gmr-GAL4 driver alone (TDP-43 wt: GMR-TDP-43 wt/w1118) or with V5-HSP67Bc. (B) WB showing expression levels of TDP-43 and V5-HSP67Bc
(*corresponds to V5-tagged HSP67Bc). a-tubulin was used as the loading control. (C) Top row, Representative pictures showing eyes from control flies (Control: GMR-
GAL4/w1118) or flies expressing human NLS-mutant TDP-43 under the control of the gmr-GAL4 driver alone (TDP-43 NLS: GMR-TDP-43 NLS/w1118) or with V5-
HSP67Bc. The eyes of flies expressing mutant TDP-43 NLS show partial loss of ommatidia, a rough phenotype and depigmentation, while co-expression with HSP67Bc
rescues the eye pigmentation and ommatidia organization. Bottom row, corresponding Richardson’s stained frontal sections showing mutation-dependent internal
degeneration that is rescued by overexpression of HSP67Bc. The quantification of the extent of eye degeneration (partially re-pigmented eyes and rough eyes) is re-
ported (***P<0.001; V5-HSP67Bc expressing flies versus control flies). Between 91 and 126 eyes/fly genotype were scored (n¼ 3 6 sem). (D) WB showing expression levels
of mutant TDP-43 NLS and HS67Bc in the eyes of 1-day-old flies. a-tubulin served as the loading control. The quantification of TDP-43 NLS protein levels is shown
(***P<0.001; V5-HSP67Bc expressing flies versus control flies). For the analysis of TDP-43-NLS protein, n¼3–5 independent samples 6 sem; each sample was obtained
from 10 to 12 fly heads.
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CG14207, which promotes HSP70-dependent protein refolding,
with WT and mutant TDP-43-NLS. However, in contrast to
HSP67Bc, CG14207 was not able to induce the autophagy-
mediated degradation of misfolded proteins, for example of ex-
panded polyglutamine sequences (24,28). Moreover, a previous
report has shown that co-expression of CG14207 with WT TDP-
43, despite decreasing the extent of its aggregation, did not de-
crease its total accumulation, further supporting the conclusion
that CG14207 does not promote TDP-43 clearance (28). In agree-
ment with these findings, the eye phenotype and the protein
levels of TDP-43 were similar in flies co-expressing the WT and
NLS-mutant TDP-43 alone or with CG14207 (Supplementary
Material, Fig. S3A–F). Taken together, our results suggest that
the protective effects on eye degeneration and the reduction of
TDP-43-NLS levels in the fly eyes that co-express HSP67Bc are
due to its pro-degradative function.
Downregulation of HSP67Bc in flies increases the
accumulation and toxicity of TDP-43-NLS
In line with this interpretation of the overexpression data,
downregulation of endogenous HSP67Bc by two independent
RNAi lines that significantly lower HSP67Bc expression (Figure
6C, Supplementary Material, Fig. S4A and (24)), significantly in-
creased the extent of TDP-43-NLS mediated eye degeneration,
with darkening and the appearance of dark patches on the eyes
(Figure 6A). As with overexpression of HSP67Bc, we observed
that knockdown of endogenous HSP67Bc in the fly eyes did not,
by itself, affect eye morphology (Supplementary Material, Fig.
S4B; compare with Supplementary Material, Fig. S2A, control
flies, and 24). Increased eye degeneration due to the downregu-
lation HSP67Bc was found to correlate with a small but signifi-
cant increase in the high molecular weight (MW) species
typically formed on expression of mutant TDP-43-NLS (as previ-
ously described (32)) and also with a highly significant accumu-
lation of endogenous (poly)ubiquitinated proteins (Figure 6B).
Interestingly, overexpression in mammalian cells of mutant
TDP-43-NLS, but not WT TDP-43, results in the accumulation of
high MW species that resemble the ubiquitinated TDP-43 high
MW smear observed in ALS and FTLD-U cases (30). Similarly, we
find here that TDP-43-NLS also has a higher propensity than
WT TDP-43 to form high MW species in vivo (Supplementary
Material, Fig. S4C); these TDP-43-NLS high MW species accumu-
late further following depletion of HSP67Bc (Figure 6). Finally,
the accumulation of (poly)ubiquitinated proteins was not ob-
served in flies where HSP67Bc expression was ubiquitously
downregulated (Figure 6C). Together, these results support the
conclusion that HSP67Bc plays an important role in the mainte-
nance of protein homeostasis under proteotoxic stress condi-
tions caused by the presence of TDP-43-NLS.
Overexpression of TDP-35 in flies leads to pupae lethal-
ity that can be rescued by co-expression of HSP67Bc
TDP-43-NLS is an artificially generated mutant that mimics the
toxicity due to cytoplasmic accumulation of TDP-43. To study
further the protective role of HSP67Bc against TDP-43 mediated
toxicity, we generated another fly model which expresses the
truncated form TDP-35 observed in ALS patients. Flies express-
ing WT TDP-43 were used as a control, and to avoid any
artefacts due to differences in transgene expression between
TDP-43 or TDP-35, both constructs encoding for TDP-43 or
TDP-35 were incorporated at the same genomic locus (33).
Furthermore, control flies that do not express TDP-43 or TDP-35
(Figure 7A,C and E) or only express HSP67Bc (Figure 7B,D and F)
were observed to have normal eyes. In agreement with our pre-
viously published data (33), overexpression of TDP-43 in the fly
eyes, alone or with HSP67Bc, caused a mild rough eye pheno-
type (Figure 7, compare G, expression of TDP-43 alone with H,
co-expression of TDP-43 and HSP67Bc), resembling the pheno-
type obtained using another independent fly model (Figure 5A)
(32). Similarly to the finding illustrated in Figure 4B, co-
expression of HSP67Bc did not affect the expression levels of
TDP-43 (Figure 7K). In addition, expression of TDP-25 in the fly
eyes caused a very mild degenerative phenotype, indistinguish-
able from that caused by WT TDP-43 (33). In contrast, expres-
sion of TDP-35 in the fly eyes led to pupae lethality (Figure 7,
compare E, negative control, with I, expression of TDP-35),
which was rescued by co-expression of HSP67Bc (Figure 7J); the
observed eclosion rate for flies co-expressing TDP-35 and
HSP67Bc was of ca. 21.4% and the expected eclosion rate is of
25%. We verified by WB that these flies indeed express both
TDP-35 and HSP67Bc (Figure 7L). However, 100% of the flies
co-expressing TDP-35 and HSP67Bc showed partial eye degener-
ation with depigmentation as shown in Figure 7J. This result
supports the conclusion that the toxicity of the TDP-35 frag-
ment is largely, but not fully, suppressed by the presence of the
chaperone HSP67Bc in fruit flies.
Overexpression of HSP67Bc also protects against
the eye degeneration induced by the ALS-causing
mutant TDP-43 M337V
A number of ALS-linked missense mutations have been identi-
fied in the gene encoding for TDP-43, including the M337V mu-
tation (34). We therefore confirmed in the present study that
overexpression in the fly eyes of ALS-causing mutant M337V
TDP-43 caused neurodegeneration (32), as shown by the partial
depigmentation with the loss of ommatidia (Figure 8A and B).
To evaluate the extent of eye degeneration, we quantified the
area of depigmentation with complete loss of ommatidia.
Figure 8 shows that co-expression of HSP67Bc with M337V TDP-
43 significantly decreased the area of the eyes characterized by
degeneration. These results further support our conclusion
that upregulation of HSP67Bc protects against TDP-43 mediated
toxicity and show that the protective effects of HSP67Bc extend
to various mutant forms of TDP-43, all characterized by
mislocalization.
Discussion
Protein misfolding and aggregation is a common feature of many
neurodegenerative disorders, including ALS, FTLD-U, polyglut-
amine diseases such as Huntington Disease (HD), Parkinson dis-
ease (PD) and Alzheimer disease (AD) and decreasing protein
aggregation has been shown to be protective in several cellular
and animal models of such conditions (18,35–40). Protection from
neurodegeneration in such disease models can be achieved
by enhancing the degradation of misfolded aggregation-prone
species that is mediated by the proteasome or autophagy, or by
boosting the expression of molecular chaperones that participate
both in protein refolding and protein degradation (15,41–44).
These key chaperones include HSPB8, a small heat shock protein
that interacts with BAG3, a co-chaperone of HSP70, and that has
been shown to facilitate the autophagic removal of a number of
aggregation-prone substrates, such as mutated polyglutamine
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Figure 6. Downregulation of HSP67Bc increases TDP-43-mediated toxicity and impairs protein homeostasis. (A) Top and middle row, representative pictures showing
eyes from flies expressing human NLS-mutant TDP-43 under the control of the gmr-GAL4 driver alone (TDP-43 NLS: GMR-TDP-43 NLS/w1118) or with two independent
sequences silencing endogenous HSP67Bc (RNAi#1 or RNAi#2). Bottom row, corresponding Richardson’s stained frontal sections showing internal degeneration in flies
with HSP67Bc depletion. The quantification of the extent of eye degeneration (rough eye, dark brown eye or eye with patches) is shown (***P < 0.001; ** P < 0.01;
HSP67Bc-depleted flies versus control flies). 50–100 eyes/fly genotypes were scored (n¼ 3 6 sem). (B): WB and data quantitation showing expression levels of mutant
NLS TDP-43, high molecular weight (MW) species and endogenous ubiquitin in the eyes of 1-day-old flies. a-tubulin was used as the loading control (***P < 0.001; ** P <
0.01; * P < 0.05; HSP67Bc-depleted flies versus control). For the analysis of monomeric TDP-43, high molecular weight (MW) TDP-43 and ubiquitinated protein, n¼3–6 in-
dependent samples 6 sem; each sample was obtained from 10 to 12 fly heads. (C) WB and data quantitation showing expression levels of endogenous ubiquitin and
HSP67Bc in the eyes of 1-day-old control flies or flies with ubiquitous expression (Act5C driver) of two independent sequences silencing endogenous HSP67Bc (RNAi#1
or RNAi#2). a-tubulin served as the loading control. n¼3–5 independent samples6 sem; each sample was obtained from 5 whole flies.
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proteins (41,45–47), a mutant SOD1 and a C-terminal truncated
fragment of TDP-43 (DC-TDP-43) associated with ALS (15,45–47),
the b-amyloid peptide associated with AD (48), mutant a-synu-
clein associated with PD (49), and of other proteins that readily
misfold (42,43,50) .
The multi-functional RNA binding protein TDP-43 is emerg-
ing as a key pathogenic protein in several neurodegenerative
diseases. Indeed, in almost all cases of sporadic and inherited
forms of ALS and FTLD-U, protein aggregates have been shown
to contain not only ubiquitin, but also TDP-43 (11,51). In ALS
and FTLD-U, several post-translational modifications of TDP-43
have been identified, which include hyperphosphorylation and
ubiquitination, as well as caspase-mediated proteolysis. TDP-43
cleavage leads to the production of 25 kDa and 35 kDa N-termi-
nally truncated fragments of TDP-43 (referred to as TDP-25 and
TDP-35). Virtually all these modifications can contribute to the
mislocalization of TDP-43 from the nucleus (where this protein
is mainly localized in healthy and resting cells) to the cytosol
(where it aggregates), thereby causing the loss of normal TDP-43
function for the modulation of splicing and transcription (11).
Moreover, TDP-43 cleavage to produce the C-terminal fragments
TDP-25 and TDP-35 appears to play a significant role in its cyto-
plasmic mislocalization and aggregation. Instead, overexpres-
sion of truncated TPD-25 or TDP-35 in cells is sufficient to
sequester a proportion of full-length TDP-43, leading to altered
RNA processing, protein homeostasis and ultimately cell
Figure 7. HSP67Bc rescues pupae lethality caused by expression of TDP-35. (A–J) Top and bottom row, representative pictures showing eyes from 1-day-old flies ex-
pressing human TDP-43 or TDP-35 under the control of the gmr-GAL4 driver alone (no chaperone) or with V5-tagged HSP67Bc (HSP67Bc). Control: gmr/51D (no chaper-
one) and gmr/51D;HSP67Bc (HSP67Bc alone). For gmr/TDP-35;HSP67Bc (TDP-35/HSP67Bc) flies, ca. 40 eyes were scored from 3 independent experiments. (K, L) Western
blot showing expression levels of TDP-43 wt (K) or TDP-35 (L) and V5-HSP67Bc in the eyes of 1-day-old flies (* corresponds to V5-tagged HSP67Bc). UAS-TDP-43 fly
extracts were used as control. a-tubulin served as the loading control. 10 fly heads/sample were used for the analysis of TDP-43 and TDP-35 protein levels.
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toxicity (11,52). In the present study, we have characterized the
propensities of TDP-25 and TDP-35 to aggregate, as compared to
TDP-43, and evaluated the protective effect of the molecular
chaperone HSPB8 both in motor neurones and fly models ex-
pressing TDP-43 or its truncated forms. The results first show
that TDP-25 and TDP-35 fragments display different aggregation
propensities, with TDP-25 being more prone to aggregation
compared to TDP-35 or TDP-43. Second, they show that, in an
attempt to maintain protein homeostasis and as found for other
types of proteinaceous aggregates (36), TDP-25 and TDP-35 frag-
ments are targeted to degradation by the proteasome and
through autophagy. In this context, HSPB8 is a critical player in
the maintenance of proteostasis, since cells overexpressing
truncated TDP-25 and TDP-35 significantly upregulate endoge-
nous HSPB8. Moreover, endogenous HSPB8 co-localizes with
TDP aggregates, supporting its role in the recognition of these
misfolded species. This observation is confirmed by our finding
that overexpression of HSPB8 decreases the total accumulation
and degree of aggregation of both TDP-25 and TDP-35 frag-
ments, while its downregulation enhances them. Combined
with our previous findings using mutated polyglutamine pro-
teins, mutant SOD1 and DC-TDP-43 (15,41,46), our results gener-
alize further the anti-aggregation function of HSPB8.
In a second series of experiments, we studied fly models ex-
pressing either mutated or truncated TDP-43 to test the protec-
tive role of HSPB8 against TDP-43 mediated toxicity in vivo.
Since the mammalian and the Drosophila melanogaster (Dm) fam-
ilies have independently evolved, and as we had previously
identified the functional ortholog of human HSPB8 in flies,
called HSP67Bc (24), we used transgenic lines, either overex-
pressing or downregulating HSP67Bc, in order to test its poten-
tial protective effects in the flies. We found that overexpression
of HSP67Bc had no significant effect on WT TDP-43 expression
levels or eye phenotype in two independent TDP-43 fly models
(32,33); instead, HSP67Bc significantly decreased the degree of
eye degeneration caused by mutant TDP-43-NLS, which accu-
mulates in the cytosol as a consequence of a non-functional
sequence of its nuclear localization signal. Conversely, downre-
gulation of HSP67Bc was found to enhance eye degeneration
mediated by TDP-43-NLS, which correlated with its accumula-
tion and with an increase in the total level of (poly)ubiquiti-
nated proteins.
We found in addition that depletion of HSP67Bc increased
the high MW species formed by mutant and mislocalized
TDP-43-NLS, rather than the monomeric species (for which we
observed a slight, but not significant, increase). Interestingly,
high MW species, as well as cytoplasmic aggregates, have been
found in cellular models expressing the specific mutant TDP-43-
NLS that we studied here in vivo (30); these high MW species are
ubiquitinated and resemble the species that accumulate in ALS
and FTLD-U. Combined with the increase in the ubiquitinated
proteins that we observed in HSP67Bc depleted flies that overex-
press TDP-43-NLS, our results support a role for HSP67Bc in
facilitating the removal of high MW, potentially aggregation-
prone, ubiquitinated species that accumulate upon proteotoxic
stress conditions such as overexpression of mutant TDP-43.
This interpretation is consistent with our findings in motor
neurone cells and with our previously published data demon-
strating that HSP67Bc promotes autophagic flux in mammalian
and Drosophila S2 cells (24,28). In accord with this finding,
co-expression of the Drosophila sHSP CG14207, which assists the
refolding of substrates in a HSP70-dependent manner, but does
not promote the degradation of aggregation-prone proteins by
autophagy (24,28), did not protect the fly eyes from the toxicity
exerted by TDP-43-NLS, nor did it change its total levels.
The protective effect of HSP67Bc was further reinforced us-
ing a fly model expressing truncated TDP-35. Again, while
HSP67Bc had no detectable effect on WT TDP-43 levels and the
observed eye phenotype, its overexpression was sufficient to
abolish the lethality of pupae caused by the TDP-35 fragment.
We have previously characterized the toxic effects caused by
overexpression of TDP-43 and TDP-25 in fly eyes and observed
that both proteins caused only a mild rough eye phenotype,
with no major differences in their effects on fly eye morphology
(33). When comparing the toxicity exerted by TDP-43 and TDP-
35, both of which were expressed from the same genomic locus,
we noticed that TDP-35 expression in fly eyes resulted in a very
strong toxic phenotype, abrogating fly eclosion. Thus, TDP-25
and TDP-35 fragments show different degrees of toxicity in flies,
a phenomenon that could be due to their different abilities to
interact with TDP-43 and to bind to RNA, since TDP-35, but not
TDP-25, co-precipitates endogenous TDP-43 in cells (52) or, al-
ternatively, to their different aggregation propensities and rates
of turnover.
Finally, overexpression of HSP67Bc also protected against
the eye degeneration induced by the ALS-causing mutant
M337V TDP-43, further generalizing its beneficial effects to dif-
ferent forms of mislocalized TDP-43.
In summary, our data provide clear evidence that upregula-
tion of HSPB8 could be an effective approach to combating those
neurodegenerative diseases that are characterized by (motor)
neurone loss and proteinaceous inclusions. Since aggregated
TDP-43 and TDP-35 also contain RNA, and as their aggregation
has an impact on RNA homeostasis, by sequestering specific
TDP-43-bound RNAs (52), it is possible that HSPB8 upregulation
might act not only on proteostasis but, by decreasing TDP-43
and truncated TDP-25 or TDP-35 aggregation, might also con-
tribute to the maintenance of normal RNA homeostasis. These
Figure 8. HSP67Bc significantly rescues the eye degeneration induced by the
ALS-causing mutant M337V TDP-43. (A) Representative pictures showing eyes
from 1-day-old control flies (Control: GMR/w1118) or flies expressing human
M337V TDP-43 under the control of the gmr-GAL4 driver alone (TDP-43 M337V:
GMR-TDP-43 M337V/w1118) or with V5-HSP67Bc. (B) Quantitation of the eye phe-
notype shown in (A). For this experiment the following eye phenotypic score
was assessed: eye degeneration score of 4 for area less than 10%; eye degenera-
tion score of 5 for area between 30 and 50%; eye degeneration score of 6 for
area between 50 and 70%. In each case 20–39 eyes/fly genotype were scored.
***P < 0.0001.
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results, therefore, suggest that it might in the future be of great
interest to examine the effects of HSPB8 on RNA homeostasis
and to explore the potential protective effects of drugs that can
upregulate HSPB8 expression for the treatment of neurodegen-
erative diseases such as ALS.
Materials and Methods
Chemicals
Dimethyl sulfoxide (DMSO), doxycycline and MG132 were
obtained from Sigma-Aldrich (St. Louis, MO, USA),
3-Methyladenine (3-MA) was obtained from Selleckchem
(Munich, Germany).
Plasmids
pEGFP-TDP-43, pEGFP-TDP-35 and peGFP-TDP-25, coding,
respectively, for the GFP-fused TDP-43 full length protein (GFP-
TDP-43) and its C-terminal 35KDa (GFP-TDP-35) or 25 KDa (GFP-
TDP-25) fragments, were kindly provided from Dr. L. Petrucelli
(11). 2xFLAG-TDP-43, 2xFLAG-TDP-35 and 2xFLAG-TDP-25 were
obtained by excising EGFP from pEGFP-TDPs plasmids (using
NheI/BamHI sites) and inserting in frame a 2xFLAG sequence,
flanked by NheI and BamHI restriction sites. pcDNA3 was from
Life Technologies Corporation (Carlsbad, CA, USA). pDsRed-
Monomer was from Clontech Lab (Mountain View, CA, USA).
pCI-HSPB8 codes for human HSPB8 (53). The pcDNA5/TO-GFP-
TDPs plasmids used for stable transfections were obtained by
excising the GFP-TDPs fragments from pEGFP-TDPs vectors us-
ing NheI-XbaI sites and cloning into the same sites of pcDNA5/
TO-NheI Vector. The pcDNA5/TO mammalian expression vector
was obtained from Life Technologies Corporation and was mod-
ified to obtain the pcDNA5/TO-NheI by inserting the BamHI and
NheI restriction sites into AflII and XbaI sites. Custom siRNA du-
plex was used to silence endogenous murine HSPB8 expression
(sense: 5’-CGGAAGAGCUGAUGGUAAAUU-3’; antisense: 5’-UUU
ACCAUCAGCUCUUCCGUU-3’) (Dharmacon, Thermo Scientific
Life Sciences Research, Waltham, MA, USA). A custom non-
targeting siRNA duplex was used as a negative control (sense:
5’-GGGUAAAGCUAGAGAGAAUUU-3’; antisense: 5’-AUUCUCU
CUAGCUUUACCCUU-3’).
Cell cultures and transfection
Immortalized mouse motor neurone cell line NSC34 (54,55) is
routinely cultured in our laboratory (45,46,56–65). Cells were
plated at 80,000 cells/well in 12-well multiwell plates for
Western Blot (WB) and Filter Retardation Assay (FRA) analysis;
for immunohistochemistry analysis, cells were plated at 35,000
cells/well in 24-well multiwell plate with coverslips. 24 h after
plating, the cells were transiently transfected with lipofect-
amine (Life Technologies Corporation)/transferrin (Sigma-
Aldrich), following the manufacture’s instructions (1lg of plas-
mid DNA, 4 ll of transferrin solution and 2 ll of lipofectamine
per well of 12-well multiwell plate). Inducible stably-transfected
GFP-TDPs-NSC34 cell lines were obtained by transiently trans-
fecting a TR4 NSC34 cell line (66,67), kindly provided by
Dr. E. Garattini (Mario Negri Institute, Milan, Italy), with
pcDNA5/TO-GFP-TDPs plasmids and selecting positive clones
with 200 lg/ml hygromycin for 3 weeks. GFP-TDPs-NSC34 se-
lected clones were cultured in low-glucose DMEM (Euroclone,
Pero, Milan, Italy) supplemented with 5% of tetracycline-free
serum (Euroclone), 100 lg/ml hygromycin (Euroclone) as
described in Locatelli et al. 2012 (66). For FRA analyses, cells
were plated at 70,000 cells/well in 12-well multiwell plate and
induced with 1 lg/ml doxycycline for 72 h.
Fly stocks
All fly stocks were maintained at 18 C on a 12:12 h light:dark
cycle at constant humidity on a standard Bloomington medium
supplemented with yeast. For all experiments, the flies were
raised at 25 C on a 12:12 h light:dark cycle at constant humidity.
Eye-specific expression of transgenes and RNAi constructs was
achieved by using the GAL4-UAS system (GAL4-dependant up-
stream activator sequence; Brand and Perrimon, 1993). The fly
stocks gmr-GAL4 (stock number 1104) and actin 5C-GAL4 (stock
number 4414) were obtained from the Bloomington Drosophila
Stock Centre. Transgenic flies expressing V5-HSP67Bc were con-
structed at Genetic Services Inc. (Sudbury, MA), and the back-
ground strain w1118 of Genetic Services was used as a control
(24). RNAi lines against Dm-HSP67Bc (CG4190) were obtained
from the Vienna Drosophila RNAi Center (VDRC). Two indepen-
dent lines were used in this study: the VDRC ID 26416, referred
to as HSP67Bc RNAi#1 and the VDRC ID 103974, referred to as
HSP67Bc RNAi#2. The fly lines expressing human WT TDP-43 or
the NLS mutant TDP-43 were a kind gift of Dr. JP Taylor (32). The
fly lines expressing human HA-tagged TDP-43, TDP-25 or TDP-
35, all incorporated at the same genomic locus (51D) on Chr. II,
were generated by Bestgene Inc (USA); the fly lines expressing
TDP-43 and TDP-25 have been previously described (33).
Microscopy and immunohistochemistry
Transfected cells were fixed 48 h after transfection with 4%
paraformaldeyde and methanol and processed as previously
described (68). To detect endogenous and overexpressed
HSPB8 protein expressions, we used a home-made rabbit poly-
clonal anti-HSPB8 (#25; dilution 1:200 in 5% nonfat milk) and
the Alexa 594 anti-rabbit secondary antibody (A11072; Life
Technologies) (dilution 1:1000 in milk). To detect FLAG-tagged
TDPs, we used the anti-FLAG mouse-monoclonal antibody
(F1804 Clone M2; Sigma) (dilution 1:200 in nonfat milk) and
the Alexa 488 anti-rabbit secondary antibody (A11070; Life
Technologies) (dilution 1:1000 un milk). Cells were stained
with DAPI to visualize the nuclei. Images were acquired with
LSM510 Meta system confocal microscope (Zeiss, Oberkochen,
Germany) and images were processed with the Aim 4.2 soft-
ware (Zeiss).
Quantification of the number of cells with GFP-TDPs or
2xFLAG-TDPs aggregates was performed on cells co-transfected
with TDPs and pDSRed-monomer (used as a transfection con-
trol) by measuring the numbers of cells with TDP aggregates,
normalized to the total number of transfected cells (pDSRed-
monomer positive cells). At least 100 cells/field were counted,
and three fields were analysed for each coverslip. The experi-
ments were performed in triplicate and the data have been ex-
pressed in each case as mean6 sem.
Light microscopy of fly eyes and histology
The effects of HSP67Bc overexpression or knockdown on eye
degeneration in the gmr-GAL4-TDP43 WT and NLS mutant, as well
as in the gmr-GAL4-TDP25 or gmr-GAL4-TDP-35 lines, were evalu-
ated by taking light microscopic images of the eyes of 1-day old
adult flies with a stereoscopic microscope model SZ40 (Olympus).
For each genotype and condition more than 100 fly eyes were
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evaluated. For fly eye histology, heads of the appropriate genotype
were collected and fixed for 2 h at room temperature in 4% para-
formaldehyde in PBS. Samples were serially dehydrated in ethanol
and processed as previously described (69).
Western blot analysis, preparation of protein extracts
and antibodies
Cells were harvested 48 h after transfection and centrifuged
5 min at 100 g at 4 C. For PBS extraction, the pellets were resus-
pended in PBS supplemented with the protease inhibitors cock-
tail (Sigma-Aldrich) and homogenized using slight sonication.
For NP40 extraction, the pellets were resuspended in lysis buffer
(150 mM NaCl, 20 mM Trizma, NP40 0.5%, 1.5 mM MgCl2, glycerol
3%, pH 7.4; Sigma-Aldrich) supplemented with complete EDTA-
free (Sigma-Aldrich) and 1mM dithiothreitol (DTT; Sigma-
Aldrich). NP40 soluble and insoluble fractions were separated by
centrifugation at 16,000 g for 15 min at 4 C. The protein content
of the soluble fraction was determined by the bicinchoninic acid
method (BCA assay, Pierce, Rockford, IL, USA). WB analysis was
performed on 12% SDS polyacrylamide gel, loading 15 lg of pro-
teins for PBS and NP40-soluble extracts or an equal volume of
the corresponding NP40-soluble fraction for NP40-insoluble ex-
tracts. Samples were electro-transferred to nitrocellulose mem-
branes (Bio-Rad Laboratories, Hercules, CA, USA) using
TransBlot Turbo Apparatus (Bio-Rad). Nitrocellulose mem-
branes were processed as previously described (15,45,46) using
the following primary antibodies: (a) rabbit polyclonal anti-GFP
HRP-conjugate to detect GFP-TDPs (MB-0712; Vector
Laboratories, Burlingame, CA, USA; dilution 1:10,000); (b) goat
polyclonal anti-actin to detect actin (sc-1616; Santa Cruz
Biotechnology; dilution 1:1000); (c) home-made rabbit polyclonal
anti-HSPB8 (#25; dilution 1:1000) to detect HSPB8 (d) rabbit poly-
clonal anti-GAPDH to detect GAPDH (dilution sc-25778; Santa
Cruz Biotechnology; 1:1000); (e) mouse-monoclonal anti-FLAG
antibody to detect FLAG-tagged TDPs (F1804 Clone M2; Sigma;
dilution 1:1000); (f) mouse-monoclonal anti-alpha-tubulin to de-
tect tubulin (F2168; Sigma; dilution 1:1000). The secondary
peroxidase-conjugated antibodies were: donkey anti-goat (sc-
2020; Santa Cruz Biotechnology; dilution 1:10,000); goat anti-
rabbit (sc-2004; Santa Cruz Biotechnology; dilution 1:10,000);
goat anti-mouse (sc-2005; Santa Cruz Biotechnology; dilution
1:10,000). Signals were detected by ClarityTM Western ECL
Blotting Substrate (Bio-Rad). Membranes were subsequently
processed with the different antibodies after stripping for
20 min at room temperature (StripABlot, EuroClone).
Protein samples from 1- to 2-day-old fly heads were pre-
pared by homogenizing circa 10 heads in 50 ml of 2% SDS lysis
buffer. The various proteins were resolved by SDS-PAGE, trans-
ferred to nitrocellulose membrane, and then processed for WB.
Mouse monoclonal a-tubulin antibody (Sigma-Aldrich) was
used as a loading control and rabbit polyclonal ubiquitin anti-
body (DAKO) was used to detect ubiquitinated proteins in fly
head extracts. Human TDP-43 in fly head extracts was detected
using the TARDBP (41–7.1) antibody (sc-100871; Santa Cruz
Biotechnology). The antibody against Dm-HSP67Bc has been
previously described (24).
Filter retardation assay, preparation of protein extracts
For transiently transfected NSC34 cells, 1.5 mg of the PBS or
NP40-soluble protein extracts (quantified used the BCA assay as
described above) were loaded onto 0.2 mm cellulose acetate
membrane (Whatman, GE Healthcare) and filtered through a
Bio-Dot SF Microfiltration Apparatus (Bio-Rad). An equal volume
of the corresponding NP40-soluble extract was loaded in the
case of NP40-insoluble extracts. Slot-blots were probed as de-
scribed for WB to detect GFP-TDPs or FLAG-TDPs retained insol-
uble species. For stably transfected GFP-TDPs-NSC34 cell lines,
cells were harvested 72 h after induction with 1 lg/ml of doxycy-
cline, and samples were prepared as described above for tran-
siently transfected cells. 9 mg of the NP40-detergent soluble
protein extracts were loaded onto cellulose acetate membranes
and filtered. An equal volume of the corresponding NP40-
soluble extract was loaded in the case of NP40-insoluble ex-
tracts. Slot-blots were probed with GFP antibody as described
above for WB. Densitometric optical analysis of slot-blots was
performed and represented as mean 6 SEM (n¼ 3).
Statistics
Cellular biochemical data were analysed using Student’s t-test.
Values represent mean6SEM of 3 replicates. Fly biochemical
data and eye morphological comparisons between genotypes
were analysed using ANOVA, followed by the Bonferroni post-
hoc or the Student’s t-test. *¼ P> 0.05; **¼ P> 0.01; ***¼ P> 0.001.
Values represent mean6SEM.
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Supplementary Material is available at HMG online.
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